Permisividad por posición | Próximas 5 jornadas desde J25 | Ordenado por facilidad
| # | Equipo | J25 | J26 | J27 | J28 | J29 | MEDIA |
|---|---|---|---|---|---|---|---|
| 1 |
FCB
|
ZAR
|
BLB
|
HIO
|
BAS
|
GCA
|
+0,8% |
| 2 |
GCA
|
BUR
|
BAS
|
ZAR
|
GIR
|
FCB
|
-0,1% |
| 3 |
VBC
|
BRE
|
UNI
|
GIR
|
RMA
|
MAN
|
-0,1% |
| 4 |
CAN
|
HIO
|
GIR
|
RMA
|
MUR
|
AND
|
-1,7% |
| 5 |
RMA
|
AND
|
BUR
|
CAN
|
VBC
|
MUR
|
-2,7% |
| 6 |
GIR
|
COV
|
CAN
|
VBC
|
GCA
|
ZAR
|
-2,8% |
| 7 |
COV
|
GIR
|
MUR
|
UNI
|
AND
|
BLB
|
-3,8% |
| 8 |
BLB
|
UNI
|
FCB
|
MAN
|
ZAR
|
COV
|
-4,1% |
| 9 |
BUR
|
GCA
|
RMA
|
BRE
|
MAN
|
HIO
|
-4,3% |
| 10 |
JOV
|
MUR
|
MAN
|
BAS
|
BRE
|
UNI
|
-5,1% |
| 11 |
MUR
|
JOV
|
COV
|
AND
|
CAN
|
RMA
|
-5,3% |
| 12 |
AND
|
RMA
|
BRE
|
MUR
|
COV
|
CAN
|
-5,5% |
| 13 |
HIO
|
CAN
|
ZAR
|
FCB
|
UNI
|
BUR
|
-6,4% |
| 14 |
BAS
|
MAN
|
GCA
|
JOV
|
FCB
|
BRE
|
-6,5% |
| 15 |
ZAR
|
FCB
|
HIO
|
GCA
|
BLB
|
GIR
|
-7,0% |
| 16 |
BRE
|
VBC
|
AND
|
BUR
|
JOV
|
BAS
|
-8,2% |
| 17 |
MAN
|
BAS
|
JOV
|
BLB
|
BUR
|
VBC
|
-9,1% |
| 18 |
UNI
|
BLB
|
VBC
|
COV
|
HIO
|
JOV
|
-9,6% |
| # | Equipo | J25 | J26 | J27 | J28 | J29 | MEDIA |
|---|---|---|---|---|---|---|---|
| 1 |
VBC
|
BRE
|
UNI
|
GIR
|
RMA
|
MAN
|
+12,6% |
| 2 |
GCA
|
BUR
|
BAS
|
ZAR
|
GIR
|
FCB
|
+6,5% |
| 3 |
CAN
|
HIO
|
GIR
|
RMA
|
MUR
|
AND
|
+4,7% |
| 4 |
BAS
|
MAN
|
GCA
|
JOV
|
FCB
|
BRE
|
+3,1% |
| 5 |
BUR
|
GCA
|
RMA
|
BRE
|
MAN
|
HIO
|
+2,9% |
| 6 |
FCB
|
ZAR
|
BLB
|
HIO
|
BAS
|
GCA
|
-2,2% |
| 7 |
ZAR
|
FCB
|
HIO
|
GCA
|
BLB
|
GIR
|
-3,8% |
| 8 |
MUR
|
JOV
|
COV
|
AND
|
CAN
|
RMA
|
-6,0% |
| 9 |
COV
|
GIR
|
MUR
|
UNI
|
AND
|
BLB
|
-6,8% |
| 10 |
GIR
|
COV
|
CAN
|
VBC
|
GCA
|
ZAR
|
-7,4% |
| 11 |
HIO
|
CAN
|
ZAR
|
FCB
|
UNI
|
BUR
|
-8,3% |
| 12 |
AND
|
RMA
|
BRE
|
MUR
|
COV
|
CAN
|
-8,6% |
| 13 |
RMA
|
AND
|
BUR
|
CAN
|
VBC
|
MUR
|
-9,5% |
| 14 |
JOV
|
MUR
|
MAN
|
BAS
|
BRE
|
UNI
|
-9,9% |
| 15 |
BLB
|
UNI
|
FCB
|
MAN
|
ZAR
|
COV
|
-11,4% |
| 16 |
MAN
|
BAS
|
JOV
|
BLB
|
BUR
|
VBC
|
-13,1% |
| 17 |
UNI
|
BLB
|
VBC
|
COV
|
HIO
|
JOV
|
-14,9% |
| 18 |
BRE
|
VBC
|
AND
|
BUR
|
JOV
|
BAS
|
-16,6% |
| # | Equipo | J25 | J26 | J27 | J28 | J29 | MEDIA |
|---|---|---|---|---|---|---|---|
| 1 |
RMA
|
AND
|
BUR
|
CAN
|
VBC
|
MUR
|
+2,8% |
| 2 |
FCB
|
ZAR
|
BLB
|
HIO
|
BAS
|
GCA
|
+1,3% |
| 3 |
GIR
|
COV
|
CAN
|
VBC
|
GCA
|
ZAR
|
-0,4% |
| 4 |
VBC
|
BRE
|
UNI
|
GIR
|
RMA
|
MAN
|
-0,9% |
| 5 |
COV
|
GIR
|
MUR
|
UNI
|
AND
|
BLB
|
-2,6% |
| 6 |
JOV
|
MUR
|
MAN
|
BAS
|
BRE
|
UNI
|
-3,0% |
| 7 |
MUR
|
JOV
|
COV
|
AND
|
CAN
|
RMA
|
-3,4% |
| 8 |
HIO
|
CAN
|
ZAR
|
FCB
|
UNI
|
BUR
|
-3,5% |
| 9 |
CAN
|
HIO
|
GIR
|
RMA
|
MUR
|
AND
|
-3,9% |
| 10 |
GCA
|
BUR
|
BAS
|
ZAR
|
GIR
|
FCB
|
-4,8% |
| 11 |
BLB
|
UNI
|
FCB
|
MAN
|
ZAR
|
COV
|
-6,2% |
| 12 |
BRE
|
VBC
|
AND
|
BUR
|
JOV
|
BAS
|
-7,6% |
| 13 |
BUR
|
GCA
|
RMA
|
BRE
|
MAN
|
HIO
|
-7,8% |
| 14 |
UNI
|
BLB
|
VBC
|
COV
|
HIO
|
JOV
|
-7,9% |
| 15 |
AND
|
RMA
|
BRE
|
MUR
|
COV
|
CAN
|
-9,6% |
| 16 |
MAN
|
BAS
|
JOV
|
BLB
|
BUR
|
VBC
|
-9,8% |
| 17 |
BAS
|
MAN
|
GCA
|
JOV
|
FCB
|
BRE
|
-10,1% |
| 18 |
ZAR
|
FCB
|
HIO
|
GCA
|
BLB
|
GIR
|
-11,7% |
| # | Equipo | J25 | J26 | J27 | J28 | J29 | MEDIA |
|---|---|---|---|---|---|---|---|
| 1 |
BLB
|
UNI
|
FCB
|
MAN
|
ZAR
|
COV
|
+5,2% |
| 2 |
FCB
|
ZAR
|
BLB
|
HIO
|
BAS
|
GCA
|
+3,3% |
| 3 |
AND
|
RMA
|
BRE
|
MUR
|
COV
|
CAN
|
+1,6% |
| 4 |
BRE
|
VBC
|
AND
|
BUR
|
JOV
|
BAS
|
-0,5% |
| 5 |
GIR
|
COV
|
CAN
|
VBC
|
GCA
|
ZAR
|
-0,8% |
| 6 |
RMA
|
AND
|
BUR
|
CAN
|
VBC
|
MUR
|
-1,4% |
| 7 |
COV
|
GIR
|
MUR
|
UNI
|
AND
|
BLB
|
-1,9% |
| 8 |
GCA
|
BUR
|
BAS
|
ZAR
|
GIR
|
FCB
|
-2,0% |
| 9 |
JOV
|
MUR
|
MAN
|
BAS
|
BRE
|
UNI
|
-2,4% |
| 10 |
MAN
|
BAS
|
JOV
|
BLB
|
BUR
|
VBC
|
-4,4% |
| 11 |
ZAR
|
FCB
|
HIO
|
GCA
|
BLB
|
GIR
|
-5,6% |
| 12 |
CAN
|
HIO
|
GIR
|
RMA
|
MUR
|
AND
|
-5,8% |
| 13 |
UNI
|
BLB
|
VBC
|
COV
|
HIO
|
JOV
|
-6,0% |
| 14 |
MUR
|
JOV
|
COV
|
AND
|
CAN
|
RMA
|
-6,5% |
| 15 |
HIO
|
CAN
|
ZAR
|
FCB
|
UNI
|
BUR
|
-7,4% |
| 16 |
BUR
|
GCA
|
RMA
|
BRE
|
MAN
|
HIO
|
-8,1% |
| 17 |
VBC
|
BRE
|
UNI
|
GIR
|
RMA
|
MAN
|
-12,0% |
| 18 |
BAS
|
MAN
|
GCA
|
JOV
|
FCB
|
BRE
|
-12,6% |